Update
OpenEvidence Hits $15 Billion Valuation
AI-driven platform OpenEvidence, valued at $15 billion as of September 2026, has seen rapid growth since its founding in 2022. The Miami-based startup has raised over $1 billion in funding, including a $250 million round led by Andreessen Horowitz and Byers Capital. Nearly two-thirds of US physicians use OpenEvidence to guide diagnoses and treatment decisions, with over 1.12 million verified clinicians on the platform. The company has expanded into specialized AI models and early-stage oncology drug development.